GenSpera To Present At The BIO Investor Forum

SAN ANTONIO--(BUSINESS WIRE)--GenSpera, Inc. (OTC/QB: GNSZ), a clinical-stage oncology drug discovery company developing a naturally occurring toxin in a targeted delivery system for solid tumors, announces that President and CEO Craig Dionne, Ph.D., is scheduled to present a corporate overview at the 14th Annual BIO Investor Forum on October 21, 2015 at 8:00 a.m. Pacific time (11:00 a.m. Eastern time). The conference is being held at Parc 55 San Francisco hotel in San Francisco.

Help employers find you! Check out all the jobs and post your resume.